updates on car-t and bcma antibodies in multiple myeloma
Published 5 months ago • 256 plays • Length 52:28Download video MP4
Download video MP3
Similar videos
-
1:02:26
myeloma care: pharmacy perspectives on antibodies and bcma car-t
-
55:48
hitting the bcma target in multiple myeloma
-
1:28:55
expert tips for using car t-cell therapy in leukemia, lymphoma, and multiple myeloma care
-
1:08:35
innovative therapy in multiple myeloma: monoclonal antibodies and bcma and non-bcma options
-
1:20:14
betting on bcma therapy in multiple myeloma
-
3:22
anti-bcma car t-cell therapy in myeloma: updates from ash 2020
-
54:38
bcma antibodies and cellular therapies in rrmm
-
4:12
car-t therapy in multiple myeloma: recent updates, clinical trials and future outlooks
-
32:28
an "off-the-shelf" approach for myeloma care: bcma antibodies
-
1:20:04
antibodies in multiple myeloma: insights and patient voices along the therapeutic journey
-
21:42
car t-cell therapy & conjugated bcma monoclonal antibodies
-
10:18
ide-cel; bb2121, a bcma-targeted car t-cell therapy, in patients with rrmm: initial karmma results
-
0:53
incorporating bcma-targeted car-t therapy in the frontline treatment of multiple myeloma
-
2:30
an update on the current status of car-t therapy in multiple myeloma
-
1:04:23
navigating from a to b and c in multiple myeloma
-
1:59:37
bcma therapy & the road to remission in myeloma
-
35:13
reaching the next level of myeloma patient care: antibody therapy and novel mechanisms of action
-
1:53
phe885, a t-charge manufactured bcma-directed car-t therapy in r/r myeloma
-
1:48
the impact of prior bcma car-t therapy on the efficacy bcma-targeting bispecifics in myeloma